Cargando…
First person – Sarah Elzinga
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077552/ http://dx.doi.org/10.1242/dmm.049033 |
_version_ | 1783684900570791936 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model’, published in DMM. Sarah is a postdoc in the lab of Eva Feldman at the University of Michigan, Ann Arbor, MI, USA, investigating immune-mediated mechanisms that promote neurodegeneration in obesity, metabolic syndrome, prediabetes and type 2 diabetes. |
format | Online Article Text |
id | pubmed-8077552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-80775522021-04-27 First person – Sarah Elzinga Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model’, published in DMM. Sarah is a postdoc in the lab of Eva Feldman at the University of Michigan, Ann Arbor, MI, USA, investigating immune-mediated mechanisms that promote neurodegeneration in obesity, metabolic syndrome, prediabetes and type 2 diabetes. The Company of Biologists Ltd 2021-04-15 /pmc/articles/PMC8077552/ http://dx.doi.org/10.1242/dmm.049033 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Sarah Elzinga |
title | First person – Sarah Elzinga |
title_full | First person – Sarah Elzinga |
title_fullStr | First person – Sarah Elzinga |
title_full_unstemmed | First person – Sarah Elzinga |
title_short | First person – Sarah Elzinga |
title_sort | first person – sarah elzinga |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077552/ http://dx.doi.org/10.1242/dmm.049033 |